Sign In

Richard Heyman

Vice Chairman of The Board of Trustees at Salk Institute for Biological Studies

Richard Heyman is a renowned professional in the field of pharmacology with a PhD from the University of Minnesota.

He has held numerous key positions in various organizations, showcasing his expertise and leadership skills.

Richard Heyman's notable organizational roles include being a Board Member at Yumanity Therapeutics, Gritstone Oncology, and ORIC Pharmaceuticals.

He has also served as Vice Chairman of The Board of Trustees at the prestigious Salk Institute for Biological Studies.

With a successful track record, Richard Heyman has been the Executive Chairman at Metacrine Inc. and the President and CEO at Seragon Pharmaceuticals and Aragon Pharmaceuticals.

His experience includes holding positions such as Chief Scientific Officer at Kalypsys, Inc., Sr. Vice President at Exelixis, Inc., CSO at X-Ceptor Therapeutics, and VP Research at Ligand Pharmaceuticals.

Richard Heyman's journey in the field started with a Postdoctoral Fellowship at the Salk Institute, showcasing his dedication to scientific research and development.

R
Add to my network

Location

Greater San Diego Area